Latest news

07 January 2026

EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan

Read more

06 January 2026

Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent

Read more

22 December 2025

Newron to Host Investor and Partnering Meetings During the J.P. Morgan Healthcare Conference Week

Read more
Read more
Growing Plant

Investor toolbox

Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, key financial data and presentations and webcasts.

Reports, Presentations and webcast
Corporate governance

Financial calendar

Financial Calendar Tabs
2026 Archive
Date Event Add to calendar
March 24, 2026 Publication of Annual Report 2025 mylink
April 23, 2026 Annual general meeting mylink
September 22, 2026 Publication of Half-Year Report 2026 mylink
Shareholders FAQ’s

Find answers to commonly asked questions.

Read more

Upcoming Events

Newron representatives will be available at the following conferences.

Read more

Contacts

Need more information?

Read more

Email alert

Sign up for our latest news and updates

Subscribe here